Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025EMJ NeurologyOpen Access

Psychedelics in Psychiatry: Interview with Christina Dalla

View Full Paper
Ask AI
Bookmark
Share

Authors

CDChristina Dalla

Discussion

Loading...

Member takes

Overview

Interview reveals insights into depression and anxiety treatment with psychedelics, highlighting neuropsychopharmacology and sex differences.

Key Points

  • Psychedelic treatments show promise in addressing depression and anxiety effectively.
  • Christina Dalla emphasizes the importance of understanding sex differences in neuropsychiatry.
  • Neuropsychopharmacology research may open new avenues for mental health treatments.
  • The discussion focuses on groundbreaking discoveries in the context of mental health therapies.

Cite This Study

Christina Dalla (2025) studied this question.

synapsesocial.com/papers/68c1afc054b1d3bfb60e746ehttps://doi.org/10.33590/emjneurol/cggr3952
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview2024 · 12 citations
  2. 2The Role of Psychedelics in Contemporary Psychological and Interdisciplinary Inquiry2025 · 2 citations
  3. 3Gregor Hasler: Three Guiding Questions — How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?2025
  4. 4Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders2026
  5. 5The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry2025 · 1 citations